March 28th 2025
Fitusiran (Qfitlia) is approved for patients 12 years and older with or without factor VIII or IX inhibitors.
Pharmacies benefitting from new programs, recognitions, Anne Burns says
March 20th 2012New programs and recognitions make 2012 a great year for community pharmacies to be more involved in medication therapy management, according to a speaker at the FMI Health & Wellness Conference in Orlando, Fla., this week.
Bootman honored as PPSI Distinguished Pharmacist of Year during APhA annual meeting
March 20th 2012J. Lyle Bootman, PhD, ScD, senior vice president for Health Sciences, dean and professor of Pharmacy, Medicine, and Public Health, University of Arizona, College of Pharmacy, was honored as the PPSI Distinguished Pharmacist of the Year, during PPSI’s annual breakfast, held during the American Pharmacists Association 2012 annual meeting in New Orleans.
FDA approves first oral contraceptive to treat heavy menstrual bleeding
March 15th 2012FDA has approved a new indication for estradiol valerate and estradiol valerate/dienogest (Natazia, Bayer HealthCare Pharmaceuticals) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus.
Study: Adding prednisone to treatment improves rheumatoid arthritis symptoms
March 15th 2012Patients' rheumatoid arthritis symptoms improved after adding prednisone at the start of a methotrexate-based treatment strategy, according to research published in the March 6 issue of the Annals of Internal Medicine.
APP Pharmaceuticals releasing more preservative-free methotrexate
March 15th 2012Continuing to work with FDA to ease the ongoing shortage of injectable methotrexate, APP Pharmaceuticals this week released another 10,000 vials of preservative-free methotrexate (Methotrexate Injection), a drug used in the treatment of pediatric oncology and hematology